Evogene Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Evogene Ltd. generated cash of -$21,577,000, which is more than the previous year. Cash used in financing activities reached the amount of $18,152,000 last year. Net change in cash is therefore -$8,208,000.
Cash Flow
| 2014 | -8.89M | -84.03M | 2.66M |
|---|---|---|---|
| 2015 | -12.40M | 17.38M | 45K |
| 2016 | -11.69M | 4.02M | 655K |
| 2017 | -15.92M | 15.24M | 814K |
| 2018 | -15.16M | 17.35M | 297K |
| 2019 | -17.36M | 37.13M | 9.00M |
| 2020 | -19.51M | 9.41M | 20.37M |
| 2021 | -24.83M | -20.44M | 30.27M |
| 2022 | -23.67M | 13.27M | 9.34M |
| 2023 | -21.57M | -4.53M | 18.15M |
EVGN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.98M | 32.32M | 46.22M | 34.74M | 5.81M | 3.43M | 3.23M | 10.22M | 5.21M | 95.45M |
Operating activities | ||||||||||
Net income | -25.95M | -29.84M | -30.44M | -26.20M | -19.11M | -20.81M | -20.83M | -19.59M | -17.21M | -14.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.61M | 2.58M | 2.23M | 2.72M | 2.76M | 2.02M | 2.14M | 2.27M | 2.43M | 2.24M |
Stock-based compensation expense | 1.87M | 1.18M | 2.60M | 4.09M | 1.57M | 0 | 2.24M | 2.94M | 4.36M | 3.23M |
| Deferred income tax benefit | 1.87M | 1.18M | 2.60M | 4.09M | 1.57M | 0 | 2.24M | 2.94M | 4.36M | 3.23M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.45M | -67K | -59K | -150K | 88K | -28K | 37K | 2.50M | -1.49M | 730K |
Inventories | 490K | -474K | -92K | -912K | -895K | 146K | 351K | -279K | -1.21M | -830K |
Accounts payable | 742K | -469K | 625K | -29K | -122K | -114K | -86K | -215K | -68K | -267K |
Cash generated by operating activities | -21.57M | -23.67M | -24.83M | -19.51M | -17.36M | -15.16M | -15.92M | -11.69M | -12.40M | -8.89M |
Investing activities | ||||||||||
Purchases Of Investments | -10.70M | -911K | -24.11M | 0 | -1.63M | -45.91M | -11.65M | -24.56M | -31.16M | -110.66M |
Investments In Property Plant And Equipment | -785K | -1.17M | -724K | -682K | -900K | -374K | -590K | -808K | -2.00M | -3.56M |
Acquisitions Net | 0 | 0 | 0 | 0 | 10M | 0 | -4.75M | -5.46M | 0 | 0 |
Cash generated by investing activities | -4.53M | 13.27M | -20.44M | 9.41M | 37.13M | 17.35M | 15.24M | 4.02M | 17.38M | -84.03M |
Financing activities | ||||||||||
Common Stock Issued | 8.44M | 21K | 29.58M | 18.65M | 10M | 0 | 683K | 0 | 296K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -836K | 9.19M | -580K | -639K | -597K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 18.15M | 9.34M | 30.27M | 20.37M | 9.00M | 297K | 814K | 655K | 45K | 2.66M |
Net Change In Cash | -8.20M | -3.34M | -13.90M | 11.48M | 28.93M | 2.37M | 199K | -6.98M | 5.00M | -90.24M |
Cash at end of period | 20.77M | 28.98M | 32.32M | 46.22M | 34.74M | 5.81M | 3.43M | 3.23M | 10.22M | 5.21M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |